Citation Impact
Citing Papers
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Alteration of cell growth and morphology by overexpression of transforming growth factor β type II receptor in human lung adenocarcinoma cells
2001
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
EGF receptor in neoplasia and metastasis
1993
STATs in oncogenesis
2000 Standout
Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease
2015
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Mitogen-Activated Protein Kinase and Cytoskeleton in Mitogenic Signal Transduction
1992
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
1994 StandoutScience
Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data
2012
Non-Smad TGF-β signals
2005 Standout
Transforming Growth Factor-β–induced Mobilization of Actin Cytoskeleton Requires Signaling by Small GTPases Cdc42 and RhoA
2002
Works of Eriko Abe being referenced
Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
2014
Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor‐negative breast cancer
2011
Alteration in growth, cell morphology, and cytoskeletal structures of KB cells induced by epidermal growth factor and transforming growth factor-β
1988